Evidence map›Paper›PMID 24586768›Full record

ArticlePloS one2014

Oligodendroglial p130Cas is a target of Fyn kinase involved in process formation, cell migration and survival.

Constantin Gonsior, Fabien Binamé, Carsten Frühbeis, Nina M Bauer, Peter Hoch-Kraft, Heiko J Luhmann, Jacqueline Trotter, Robin White

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Constantin GonsiorDepartment of Biology, Molecular Cell Biology, Johannes Gutenberg-University of Mainz, Mainz, Germany.
Fabien BinaméDepartment of Biology, Molecular Cell Biology, Johannes Gutenberg-University of Mainz, Mainz, Germany.
Carsten FrühbeisDepartment of Biology, Molecular Cell Biology, Johannes Gutenberg-University of Mainz, Mainz, Germany.
Nina M BauerInstitute of Physiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Peter Hoch-KraftDepartment of Biology, Molecular Cell Biology, Johannes Gutenberg-University of Mainz, Mainz, Germany.
Heiko J LuhmannInstitute of Physiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Jacqueline TrotterDepartment of Biology, Molecular Cell Biology, Johannes Gutenberg-University of Mainz, Mainz, Germany.
Robin WhiteInstitute of Physiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Johannes Gutenberg University Mainz · DEUniversity Medical Center of the Johannes Gutenberg University Mainz · DE

Funding

Preclinical Development of Novel MEK1/2 Inhibitors to Treat Inherited CardiomyopaR41TR001008 · NCATS · CHEMINPHARMA, LLC · PI KHIRE, UDAY R · 2013 to 2013
$105k
NCATS NIH HHS R41 TR001008
6 · The paper itself

Abstract

Oligodendrocytes are the myelinating glial cells of the central nervous system. In the course of brain development, oligodendrocyte precursor cells migrate, scan the environment and differentiate into mature oligodendrocytes with multiple cellular processes which recognize and ensheath neuronal axons. During differentiation, oligodendrocytes undergo dramatic morphological changes requiring cytoskeletal rearrangements which need to be tightly regulated. The non-receptor tyrosine kinase Fyn plays a central role in oligodendrocyte differentiation and myelination. In order to improve our understanding of the role of oligodendroglial Fyn kinase, we have identified Fyn targets in these cells. Purification and mass-spectrometric analysis of tyrosine-phosphorylated proteins in response to overexpressed active Fyn in the oligodendrocyte precursor cell line Oli-neu, yielded the adaptor molecule p130Cas. We analyzed the function of this Fyn target in oligodendroglial cells and observed that reduction of p130Cas levels by siRNA affects process outgrowth, the thickness of cellular processes and migration behavior of Oli-neu cells. Furthermore, long term p130Cas reduction results in decreased cell numbers as a result of increased apoptosis in cultured primary oligodendrocytes. Our data contribute to understanding the molecular events taking place during oligodendrocyte migration and morphological differentiation and have implications for myelin formation.

Indexed as

AnimalsAxonsCell MovementCells, CulturedCell SurvivalCrk-Associated Substrate ProteinMiceOligodendrogliaPhosphorylationProto-Oncogene Proteins c-fynCrk-Associated Substrate ProteinProto-Oncogene Proteins c-fyn

Identifiers

PMID24586768
PMCPMC3931761
OpenAlexW2121513532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.